1. Fliser D, Laville M, Covic A et al. European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-inducednephropathy. The ad-hoc working group of ERBP. Nephrol Dial Transplant 2012; 27 (12): 4263–72.
2. Lameire N, Adam A, Becker CR et al. CIN Consensus Working Panel. Baseline renal function screening. Am J Cardiol 2006; 98 (6A): 21K–26K.
3. Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes inthe absence of iodinated contrast material: implications for studies of contrastnephrotoxicity. Am J Roentgenol 2008; 191 (2): 376–82.
4. Rudnick MR, Goldfarb S, Tumlin J. Contrast-induced nephropathy: is the pictureany clearer? Clin J Am Soc Nephrol 2008; 3: 261–2.
5. Lee PT, Chou KJ, Liu CP et al. Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. J Am Coll Cardiol 2007; 50 (11): 1015–20.
6. Волгина Г.В., Козловская Н.Л., Щекочихин Д.Ю. Клинические рекомендации по профилактике, диагностике и лечению контраст-индуцированной нефропатии. http://nonr.ru/?page_id=3178
7. Батюшин М.М., Повилайтите П.Е. Клиническая нефрология: руководство. Элиста: Джангар, 2009.
8. Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction ofcontrast-induced nephropathy after percutaneous coronary intervention: developmentand initial validation. J Am Coll Cardiol 2004; 44 (7): 1393–9.
9. Stacul F, van der Molen AJ, Reimer P et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiology 2011; 21 (12): 2527–41.
10. Solomon RJ, Mehran R, Natarajan MK et al. Contrast-inducednephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrology 2009; 4 (7): 1162–9.
Авторы
М.М.Батюшин
ГБОУ ВПО Ростовский государственный медицинский университет Минздрава России